Substance and claimed effects

Benign paroxysmal positional vertigo (BPPV) is a mechanical inner-ear disorder caused by displacement of otoconia — calcium carbonate crystals (otoliths) — from the utricular macula into one or more of the three semicircular canals. With the crystals lodged in a canal, head positions that move endolymph past them generate a false signal of rotation, producing brief but violent vertigo, characteristic positional nystagmus, and frequently nausea (Kim & Zee 2014; von Brevern et al. 2015). It is the single most common cause of vertigo across the lifespan, with lifetime prevalence around 2.4% in the general population and one-year incidence near 0.6% (von Brevern et al. 2007). The entry covers the substance — displaced otoconia and the canal-mechanics they cause — and the meaningful consequences that follow: positional vertigo, nausea, fall risk (especially in older adults), the anxiety/withdrawal pattern of untreated cases, sleep disruption from rolling-over attacks, daily functional impairment, and resolution through canalith-repositioning maneuvers (Epley, Semont, BBQ-roll). Surgical and pharmacological lanes are noted but not the recommended route.

Evidence by addressing question

mechanism

Two competing mechanism models, both now considered correct for different subtypes. Canalithiasis (Hall, Ruby, McClure 1979; Epley 1980) holds that free-floating otoconia in the canal's endolymph create a brief gravity-dragged current that deflects the cupula after a 1–5 second latency and fatigues within 60 seconds — matching the time course of typical posterior-canal BPPV. Cupulolithiasis (Schuknecht 1969) holds that otoconia adhere to the cupula itself, making it gravity-sensitive and producing longer, non-fatiguing nystagmus — fitting the persistent horizontal-canal variant (Kim & Zee 2014; Furman & Cass 1999). The posterior canal accounts for 60–90% of cases because of its dependent position when the head is upright; the horizontal canal accounts for 5–30%; the anterior canal is rare and contested (Bhattacharyya et al. 2017). Why otoconia detach in the first place: age-related otoconial degeneration (matrix demineralisation accelerating after age 40), head trauma, prolonged bed rest, viral neurolabyrinthitis, vitamin D deficiency reducing otoconial calcium incorporation, and idiopathic mechanisms. Vitamin D's role has biological plausibility (otoconia are calcium-carbonate over a protein matrix; calcium homeostasis depends on vitamin D) and is supported by interventional data (Jeong et al. 2020).

evidence

Diagnosis is positional. The Dix-Hallpike test is the reference standard for posterior-canal BPPV; the supine roll test (Pagnini-McClure) for horizontal canal. Both are listed as strong-recommendation diagnostic standards in the AAO-HNS clinical practice guideline (Bhattacharyya et al. 2017) and the Bárány Society consensus criteria require characteristic positional nystagmus on these maneuvers, not symptoms alone (von Brevern et al. 2015). Treatment: the 2014 Cochrane review of 11 trials (n=745) found that a single Epley maneuver versus sham/control roughly tripled the odds of symptom resolution within a week (odds ratio ~4.4) and roughly quadrupled the odds of converting a positive Dix-Hallpike to negative (OR ~9.6), with absolute symptom-resolution rates around 60–80% after one Epley versus 10–20% with sham (Hilton & Pinder 2014). The original Epley case series reported 100% resolution after 1–2 maneuvers in 30 patients followed for 6 months — a number later trials moderate but do not refute (Epley 1992). Resolution often happens during the maneuver itself; most remaining cases resolve within 1–2 weeks of repeat home maneuvers. Recurrence is real: 5-year recurrence in posterior-canal BPPV runs 30–50% in cohort series (Lopez-Escamez et al. 2005). Vitamin D supplementation in deficient patients reduces recurrence: a randomized open-label trial of 957 patients with confirmed BPPV showed annual recurrence dropped from 1.10 episodes per person-year in controls to 0.83 episodes per person-year in the vitamin D + calcium arm (24% relative reduction) among those with baseline 25-OH-D below 20 ng/mL (Jeong et al. 2020). A smaller earlier trial in patients with severe deficiency (<10 ng/mL) showed even larger absolute reductions (Talaat et al. 2016).

protocol

The Epley canalith repositioning maneuver for posterior-canal BPPV is a four-position sequence: (1) sit upright with head turned 45° toward the affected ear, then rapidly lie supine with head extended over the table edge (≈20° head-hang) for 30–60 seconds (this is also the Dix-Hallpike's terminal position; nystagmus and vertigo will fire); (2) rotate the head 90° toward the unaffected ear, hold 30–60 seconds; (3) roll the body onto the unaffected side while turning the head another 90° so the nose points toward the floor, hold 30–60 seconds; (4) sit up with head still turned, then face forward (Epley 1992; Bhattacharyya et al. 2017). The maneuver works because each transition slides the otoconia under gravity around the canal's loop and out into the utricle's vestibule. Home self-treatment using a patient-modified Epley is now standard, supported as a strong recommendation in the AAO-HNS 2017 guideline update for cases of confirmed posterior-canal BPPV (Bhattacharyya et al. 2017). For horizontal-canal BPPV the Lempert (BBQ) roll or Gufoni maneuver is used. Brandt-Daroff exercises (a habituation protocol of repeated lateral head-down positions) are an alternative for unresolved cases or as adjunct (Brandt & Daroff 1980) but inferior to Epley as first-line. Vestibular suppressants (meclizine, benzodiazepines) are explicitly recommended against as routine therapy because they suppress central compensation and don't address the mechanical cause (Bhattacharyya et al. 2017).

contraindications

The maneuver requires moving the neck and trunk into positions that may be contraindicated by: severe cervical spine disease, recent cervical or lumbar surgery, severe carotid stenosis (rotation can compromise vertebral artery flow in rare cases), unstable cardiovascular disease, high-grade cervical disc herniation, severe rheumatoid arthritis of the cervical spine, recent retinal detachment surgery. Modified maneuvers (e.g., performed seated or in the Semont position) can be substituted (Bhattacharyya et al. 2017). The bigger contraindication is misdiagnosis: vertical or pure-torsional positional nystagmus with no latency and no fatigability ("central positional vertigo") suggests a posterior-fossa lesion (cerebellar stroke, MS plaque, tumor) and demands imaging, not an Epley (Kim & Zee 2014). Red flags requiring urgent evaluation rather than self-treatment: vertigo lasting continuously over hours, focal neurologic signs (diplopia, dysarthria, limb weakness), sudden unilateral hearing loss, severe headache.

misconceptions

The dominant misconception in primary care and in patients is that vertigo is treated with vestibular suppressants. Older case series and reimbursement data show meclizine and benzodiazepines are still the most-prescribed first-line response to dizziness in many practices, despite explicit guideline recommendations against (Bhattacharyya et al. 2017). A second misconception is that BPPV is a "psychogenic" or anxiety problem — the felt experience (sudden, terrifying spinning) can produce panic, autonomic surge, and avoidance behavior that mimics anxiety disorders, and BPPV is missed accordingly. A third: that BPPV is a serious or chronic disease. It is mechanical, often single-episode, and curable in minutes — but it is also the leading unrecognized cause of dizziness in older adults presenting to falls clinics. A landmark study of 100 consecutive geriatric patients with dizziness found 9% had unrecognized BPPV; among those with falls, the proportion was higher, and they had carried the diagnosis-free dizziness for a mean of years (Oghalai et al. 2000). A fourth: that the Dix-Hallpike or Epley is dangerous — both are well-tolerated; the most common adverse event is transient nausea or vomiting during the maneuver.

failure-modes

Failures of canalith repositioning have specific causes. (1) Wrong canal targeted — clinician (or patient) assumed posterior canal when symptoms are actually horizontal-canal; horizontal-canal BPPV needs BBQ-roll, not Epley. (2) Wrong side targeted — picking the wrong ear; about half of patients can't reliably localize which ear is involved without nystagmus observation. (3) Multi-canal involvement — head trauma cases often involve more than one canal. (4) Canal switch — the maneuver moves otoconia from posterior to horizontal canal mid-procedure, changing the symptom pattern. (5) Reformation — recurrence within days, sometimes the same night, especially in deficient or aging patients (Lopez-Escamez et al. 2005). (6) Wrong diagnosis — the patient has vestibular migraine, Ménière's disease, vestibular neuritis, or a central cause; positional triggers exist but the underlying disorder is different. The AAO-HNS guideline recommends a clinician re-evaluation at 1 month if symptoms persist (Bhattacharyya et al. 2017).

practicalities

Cost and access: a primary-care or ENT visit covers diagnosis and an in-office Epley in most healthcare systems; a vestibular-trained physical therapist visit typically runs $80–$200 out-of-pocket where not covered. The maneuver itself is free to repeat at home indefinitely. No equipment is needed beyond a bed or flat surface and roughly five minutes. Time-to-resolution: a single in-office Epley resolves symptoms in about 80% of confirmed posterior-canal cases within a week (Hilton & Pinder 2014). Home self-Epley videos from academic medical centers (e.g., the AAO-HNS patient handout linked from the 2017 guideline, Carol Foster's "half-somersault" maneuver demonstrations) make the technique accessible, but the diagnostic step is the part most patients can't self-perform — knowing which ear and canal to target requires either an in-clinic Dix-Hallpike or a careful self-Dix-Hallpike with someone observing eye movements. Post-maneuver restrictions (sleeping upright, avoiding the affected side for 24–48 hours) were once standard but the 2017 guideline notes they are not necessary based on trial data — the maneuver works without them (Bhattacharyya et al. 2017).

stakes

Untreated BPPV is not benign in older adults. Cross-sectional and falls-clinic data link unrecognized BPPV to falls and fractures: in geriatric patients with documented falls, 9–30% have BPPV across series, often unrecognized (Oghalai et al. 2000; Bhattacharyya et al. 2017). The pathway is mechanical (sudden vertigo on bed-exit or head-turn → loss of balance) but also behavioral: chronic positional vertigo produces an avoidance pattern — sleeping propped up, avoiding bending or looking up, restricting head movement, withdrawing from driving — that deconditions the vestibular system and the postural muscles further. Health-related quality-of-life impact in untreated BPPV is comparable to other chronic vestibular conditions and improves substantially after repositioning therapy (Lopez-Escamez et al. 2005). Mood: anxiety and depression are elevated in BPPV cohorts before treatment and decline after resolution. Days of work lost in working-age adults with untreated symptoms can run weeks to months while the patient cycles through GP visits, meclizine prescriptions, and CT scans before someone performs a Dix-Hallpike.

payoff

The defining feature of BPPV is that the payoff timeline is extraordinarily short. The single Epley resolves the underlying mechanical fault in roughly two-thirds to four-fifths of confirmed posterior-canal cases on the spot; another 10–15% resolve within a week of a repeat home maneuver; most of the rest within two weeks (Hilton & Pinder 2014; Bhattacharyya et al. 2017). The felt experience is unusually sharp for a medical intervention: many patients report that the room stops spinning during the maneuver itself or by the time they sit up. Compared with the months- or years-long ambiguous "dizziness" trajectory typical of unrecognized cases, this is one of medicine's cleaner before/after deltas. Health-related quality-of-life scores rebound within weeks (Lopez-Escamez et al. 2005). Recurrence happens — but recurrence is itself low-stakes once the patient knows the protocol; the next episode is again resolvable in minutes, at home, with no clinical visit.

out-of-scope

Adjacent disorders the article should signpost rather than cover: vestibular migraine (positional but without the latency-fatigue-torsional-up-beating Dix-Hallpike signature, often paired with headache history), Ménière's disease (longer attacks, hearing loss, tinnitus), vestibular neuritis (constant rather than positional, days to weeks), persistent postural-perceptual dizziness (3PD), central positional vertigo from a posterior-fossa lesion (red-flag features). Bilateral vestibular hypofunction, superior canal dehiscence syndrome, and vestibular schwannoma are different entities. Vitamin D status and falls prevention deserve their own entries; cervical-spine pathology likewise.

The credibility range

Optimist case

BPPV is one of the cleanest mechanical-cause/mechanical-cure stories in medicine. The mechanism is established by histology (otoconia in canal lumens, Schuknecht 1969 cupulolithiasis demonstration), confirmed by direct visualization in cadaveric and surgical specimens, and explains the precise time course (latency, crescendo-decrescendo, fatigability) of the symptoms. The maneuver works because physics dictates it must work: rotating a sealed canal under gravity moves free-floating particles in predictable directions. The Cochrane review (Hilton & Pinder 2014) shows large, replicable effect sizes for the Epley vs. sham across 11 trials. The AAO-HNS guideline strongly recommends the maneuver with high-quality evidence. The cost is zero, the side-effects are transient nausea, and a substantial fraction of falls in older adults trace to unrecognized BPPV that could be cured in five minutes. Vitamin D supplementation in deficient patients adds a recurrence-prevention layer with a randomized trial backing it (Jeong et al. 2020). On felt experience the intervention is one of the most dramatic in outpatient medicine.

Skeptic case

The optimist numbers reflect confirmed posterior-canal BPPV diagnosed by trained clinicians using positional testing. Real-world primary care misses the diagnosis routinely (Oghalai et al. 2000), and the maneuver's effect-size advantage shrinks when applied empirically without a positive Dix-Hallpike. Horizontal-canal and multi-canal BPPV are harder to treat and undercounted in the cleanest trials. Recurrence is high — 30–50% over 5 years (Lopez-Escamez et al. 2005) — and the literature on durable cure is thinner than the literature on acute resolution. Many "dizziness" patients in the community have overlapping vestibular migraine or 3PD where Epley does nothing; the maneuver is over-applied in some settings. The vitamin D evidence is one large open-label trial (not blinded; Jeong et al. 2020) plus smaller studies, with the effect concentrated in the deficient subgroup — generalisation to repleted patients is unsupported. Self-Epley risks empirical use without diagnostic certainty: a patient who Epleys themselves for vestibular migraine gets no benefit and may delay correct workup.

Author's call

Strongly on the optimist side for confirmed posterior-canal BPPV; cautiously optimist for self-treatment when the diagnostic signs are unambiguous. The article frames it as: recognize the pattern, get a Dix-Hallpike, do the Epley — a high-payoff respond-protocol that primary care chronically underuses. The entry rates evidence at 5 (multiple RCTs, Cochrane, AAO-HNS guideline), controversy at 0 (no serious dispute on the mechanism or the maneuver), short-term health benefit at 4–5 (one of the most felt resolutions in outpatient medicine), and longevity at 2–3 (falls prevention is real but indirect and only material for older adults). Vitamin D prophylaxis is noted but lives upstream in its own entry.

Stakeholder and incentive map

Pushers: vestibular physical therapists (their bread and butter); otologists / neurotologists; the AAO-HNS guideline body (financial stake is reputational, not commercial). YouTube creators (Carol Foster's "half-somersault" video has tens of millions of views) and Reddit's r/vestibular community provide significant patient-to-patient transmission of the maneuver — community signal here is well-aligned with the evidence base, an unusual case. Pushback / counter-incentives: primary-care practice patterns favour the meclizine prescription (faster visit, no need to perform Dix-Hallpike, billing aligned), and ER throughput pressures push CT-scan-and-discharge-with-meclizine over a 90-second bedside Dix-Hallpike. Pharmaceutical interests are modest — meclizine and benzodiazepines are off-patent generic. The maneuver itself has no commercial owner, which both explains its slow adoption (no one promotes it) and its credibility (no commercial bias in trials).

Population variability

Age: incidence rises sharply after 40 and peaks 50–70 (von Brevern et al. 2007). The age-related rise reflects otoconial degeneration. Sex: women are affected roughly 2–3× more than men, partly mediated by post-menopausal calcium / vitamin D / estrogen interactions on otoconial maintenance. Trauma: head injury (including whiplash) is the dominant precipitant in younger adults and tends to produce bilateral or multi-canal disease. Vitamin D: deficient patients (25-OH-D <20 ng/mL) have higher prevalence and recurrence; repletion reduces both (Jeong et al. 2020; Talaat et al. 2016). Migraine: vestibular migraine overlaps clinically and is a differential rather than a comorbidity. Osteoporosis and osteopenia: associated with increased BPPV risk in observational studies, consistent with the bone-calcium-otoconia axis. Bed rest, post-surgical immobility, and dental-chair positioning are documented precipitants. Ménière's disease patients have higher rates of secondary BPPV.

Knowledge gaps

Open questions: (1) the molecular biology of otoconial detachment — why a specific crystal detaches at a specific moment is not understood; (2) optimal post-Epley positioning — whether any restriction matters has been contested for two decades and the latest guideline says no, but adherence to restrictions in trials varies; (3) home-Epley diagnostic accuracy without clinician confirmation — there is no large trial of pure-self-diagnosis-plus-self-treatment outcomes; (4) durable recurrence prevention beyond vitamin D — whether bisphosphonates, calcium, exercise, or sleep position changes meaningfully reduce recurrence is not established; (5) the boundary with vestibular migraine and 3PD — overlapping populations and treatment misdirection are a recognised but unsolved diagnostic problem; (6) whether the imaging-negative "central positional vertigo" group hides treatable lesions; (7) optimal management of multi-canal and bilateral BPPV after head trauma. A randomised trial of empirical self-Epley vs. structured-diagnosis-then-Epley in the general population would change current practice if it ran.

Scope vs. brief. The brief named balance, falls, nausea, daily function, and resolution via canalith repositioning — all five are covered end-to-end. Falls and balance land in stakes; nausea is anchored in mechanism and re-mentioned in the Epley action callout; daily function is the centre of gravity in stakes and payoff; the Epley itself is the protocol section. No silent narrowing.

Action type. Picked respond over know because the entry's payload is a concrete protocol to execute when a symptom hits, not awareness-only. respond with as-needed cadence matches the recurrence pattern honestly — first episode triggers the diagnosis, recurrences trigger home self-Epley.

Audience scoping left absent. BPPV peaks 50–70 and is 2–3× more common in women, but younger adults get it after head trauma and the recognition pattern matters for any adult. Scoping to 60+ would understate the under-fifty post-trauma cases; scoping to female would mislead the male readers it does affect. Left unscoped intentionally.

Contraindications field empty. The closed contraindication vocabulary (pregnancy, blood-thinners, kidney-disease, etc.) does not include the maneuver's real contraindications — cervical spine disease, carotid stenosis, recent retinal surgery. Rather than smuggle a poor fit (e.g. cardiac-condition), the article's contraindications section carries the real warnings in prose. Flag for the schema team if the closed list should be extended.

Rating call on health_short_term (4 not 5). Resolution after Epley is one of the most felt deltas in outpatient medicine, but the post-state is restoration of baseline rather than a new better baseline, so 4 ("substantial day-to-day quality-of-life lift") sits more honestly than 5 ("new baseline").

Vitamin D handled lightly. The Jeong 2020 trial and Talaat 2016 data support repletion in deficient patients for recurrence prevention, but vitamin D is its own substance and warrants its own entry. Mentioned in out-of-scope and signalled by related: ["vitamin-d"] rather than expanded inside this article.

Self-Epley framing. Erred on the "clinician confirms once, then home maneuver" framing rather than "watch a YouTube and do it" — the failure-modes section reflects the real risk of empirical use without diagnostic certainty. Carol Foster's half-somersault and pure self-treatment trials are mentioned in the research dossier but kept out of the article to avoid pushing patients past the diagnostic step.

Future-link candidates. vitamin-d, falls-prevention, vestibular-migraine, menieres-disease, vestibular-neuritis, persistent-postural-perceptual-dizziness. The first two are listed in related; the rest are signposted in the article's out-of-scope section.

Separate-entry candidates. Vestibular rehabilitation as a category (Brandt-Daroff exercises, gaze stabilization, habituation) is broader than BPPV and warrants its own entry. The post-BPPV 3PD subset (chronic visual-motion sensitivity) is large enough in clinical practice that it likely deserves its own entry too.